A total of 709 patients were enrolled in CheckMate 274, including 353 patients (of whom 140 patients had PD-L1 ≥ 1%) who were randomly assigned to take nivolumab 240 mg every 2 weeks ...
Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback